These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 4816412)

  • 21. The container size/volume relationship in particulate contamination.
    Green H; McNelis J; Steinman S
    J Parenter Drug Assoc; 1979; 33(6):319-25. PubMed ID: 261582
    [No Abstract]   [Full Text] [Related]  

  • 22. Studies on microbial contamination of infusion fluids arising from drug additions and administration.
    Ernerot L; Thorén S; Sandell E
    Acta Pharm Suec; 1973 May; 10(2):141-6. PubMed ID: 4728099
    [No Abstract]   [Full Text] [Related]  

  • 23. Glass particle contamination in single-dose ampules.
    Carbone-Traber KB; Shanks CA
    Anesth Analg; 1986 Dec; 65(12):1361-3. PubMed ID: 3777468
    [No Abstract]   [Full Text] [Related]  

  • 24. [Study of insoluble contaminants in large-volume parental infusion fluids, II. Evaluation of the degree of contamination with insoluble particles of parenteral infusion fluids produced by the pharmaceutical industry and hospital pharmacies].
    Pawlaczyk J; Nowacka D; Wawrzyńczak D
    Acta Pol Pharm; 1982; 39(1-3):151-7. PubMed ID: 7180545
    [No Abstract]   [Full Text] [Related]  

  • 25. Glass particle contamination: influence of aspiration methods and ampule types.
    Sabon RL; Cheng EY; Stommel KA; Hennen CR
    Anesthesiology; 1989 May; 70(5):859-62. PubMed ID: 2719321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Insoluble contaminants in large-volume parenteral infusion fluids. Use of the particle counter LZ-2].
    Pawlaczyk J; Nowacka D
    Acta Pol Pharm; 1981; 38(4):473-8. PubMed ID: 7331835
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of factors influencing ampoule secondary particulate contamination. A strategy for its reduction in small volume parenterals.
    Bernuzzi M; Raggi P; Montanari L
    Boll Chim Farm; 1991 Sep; 130(8):323-8. PubMed ID: 1801862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of particles in intravenous fluids using scanning electron microscopy.
    Levinson RS; Allen LV; Stanaszek WF; Mills S
    Am J Hosp Pharm; 1975 Nov; 32(11):1137-41. PubMed ID: 1190235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bacteriological and technical testing of an 0.2-micrometer air-eliminating infusion filter (author's transl)].
    Beham A; Necek S
    Anaesthesist; 1981 Aug; 30(8):427-9. PubMed ID: 7283108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A strategy for reducing particulate contamination on opening glass ampoules and development of evaluation methods for its application.
    Lee KR; Chae YJ; Cho SE; Chung SJ
    Drug Dev Ind Pharm; 2011 Dec; 37(12):1394-401. PubMed ID: 21702739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Particles in intravenous solutions: a review.
    Thomas WH; Lee YK
    N Z Med J; 1974 Aug; 80(522):170-8. PubMed ID: 4608302
    [No Abstract]   [Full Text] [Related]  

  • 32. Filtration of Glass Delamination Particles with West Pharmaceutical Vial Adapters.
    Zarour-Shalev EH; Ovadia Y; Tuchmay O; Reynolds G; Lev N
    PDA J Pharm Sci Technol; 2015; 69(6):669-76. PubMed ID: 26659100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Letter: Particulate matter in Ancef and Kefzol.
    Turco SJ; Davis NM; Bhatia R
    Am J Hosp Pharm; 1974 Mar; 31(3):222 passim. PubMed ID: 4819435
    [No Abstract]   [Full Text] [Related]  

  • 34. Particulate evaluation of parenteral nutrition solutions by electronic particle counting and scanning electron microscopy.
    Akers MJ; Schrank GD; Russell S
    Am J Hosp Pharm; 1981 Sep; 38(9):1304-7. PubMed ID: 6792911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ampins--the problems of "clear solution" and of particle shedding.
    Ernerot L
    Acta Pharm Suec; 1968 Apr; 5(2):101-10. PubMed ID: 5673469
    [No Abstract]   [Full Text] [Related]  

  • 36. Evaluation of a disposable rubber closure or bulk irrigating solutions.
    Newton DW; Rogers AG; Croswell RW; Hendrix L
    Am J Hosp Pharm; 1972 Aug; 29(8):678-83. PubMed ID: 5052414
    [No Abstract]   [Full Text] [Related]  

  • 37. Theoretical aspects of particulate matter monitoring by microscopic and instrumental methods.
    Schroeder HG; Deluca PP
    J Parenter Drug Assoc; 1980; 34(3):183-91. PubMed ID: 6901774
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of membrane filtration on 10-mg/ml cefazolin admixtures.
    Stennett DJ; Simonson W; Ayres JW
    Am J Hosp Pharm; 1979 May; 36(5):657-60. PubMed ID: 453218
    [No Abstract]   [Full Text] [Related]  

  • 39. Final in-line filtration: removal of contaminants from IV fluids and drugs.
    Rapp RP; Bivins BA
    Hosp Formul; 1983 Dec; 18(12):1124-8. PubMed ID: 10264358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Filter systems for the prevention of material and bacterial contamination].
    Ahnefeld FW; Dick W
    Klin Anasthesiol Intensivther; 1977; (14):131-8. PubMed ID: 926679
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.